In a letter to blood banks directors and haemophilia treatment centre coordinators Armour recommended that lots of HT Factorate concentrates derived from non-tested plasma should not be used and that they would arrange for centres to exchange any inventory of product manufactured from untested plasma at no cost to the centres.